Drug Trial Radar · NCT05046795
Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Last checked: Nov 19, 2026Latest source record: Nov 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
258
Actual
Start
Nov 10, 2021
Primary completion
Jul 26, 2023
Study completion Jul 26, 2023
Sponsor
- Lead sponsor
- Mylan Pharma UK Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase III clinical study to assess the efficacy and safety of Revefenacin inhalation solution 175 mcg administered once daily via nebulization for 12 weeks compared to placebo in a population of Chinese subjects with moderate to very severe COPD.
Conditions
- COPD
Interventions
Revefenacin 175 mcg in 3 ML Inhalation SolutionDrug
Revefenacin
Placebo inhalation solution QDDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Trough FEV1 on Day 85Time frame: Baseline and Day 85
- Trough FEV1 on Day 85 - Sensitivity Analysis With Missing Data ImputedTime frame: Baseline, Day 29, Day 57 and Day 85
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Anhui Medical University - Hefei First People's Hospital
Hefei, Anhui, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
The Third Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
The Second Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
Affiliated Hospital of Guangdong Medical University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Gunagdong, China
Hainan General Hospital
Haikou, Hainan, China
The First Hospital of Changsha
Changsha, Hunan, China
Inner Mongolia Baogang Hospital
Baotou, Inner Mongolia, China
The First Affiliated Hospital of Baotou Medical College - Respiration
Baotou, Inner Mongolia, China
Inner Mongolia People's Hospital
Hohhot, Inner Mongolia, China
Affiliated Hospital of Inner Mongolia Medical College
Hohhot, Inner Mongolia, China
Jiangsu Jiangyin People's Hospital
Jiangyin, Jiangsu, China
Zhongda Hospital, Southeast University - Pulmonology
Nanjing, Jiangsu, China
Nanjing Jiangning Hospital
Nanjing, Jiangsu, China
Wuxi People's Hospital
Wuxi, Jiangsu, China
Yangzhou First People's Hospital
Yangzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Nanchang University - The Second Affiliated Hospital
Nanchang, Jiangxi, China
Jiangxi Pingxiang People's Hospital
Pingxiang, Jiangxi, China
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
Yanbian university hospital
Yanji, Jilin, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Shanghai Pudong New Area People's Hospital
Shanghai, Shanghai Municipality, China
Sichuan University - West China Hospital
Chengdu, Sichuan, China
Tianjin Medical University General Hospital - Respiration
Tianjin, Tianjin Municipality, China
The First Center hospital of Tianjin
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Xinjiang Medical University - Hospital
Ürümqi, Xinjiang, China
Dongyang People's Hospital
Dongyang, Zhejiang, China
Xinhua Hostipal of Zhejiang Province
Hangzhou, Zhejiang, China
Huzhou Central Hospital
Huzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.